183 related articles for article (PubMed ID: 35008352)
1. CNV Hotspots in Testicular Seminoma Tissue and Seminal Plasma.
Raos D; Abramović I; Tomić M; Vrtarić A; Kuliš T; Ćorić M; Ulamec M; Katušić Bojanac A; Ježek D; Sinčić N
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008352
[TBL] [Abstract][Full Text] [Related]
2. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
[TBL] [Abstract][Full Text] [Related]
3. Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.
Fitarelli-Kiehl M; Yu F; Ashtaputre R; Leong KW; Ladas I; Supplee J; Paweletz C; Mitra D; Schoenfeld JD; Parangi S; Makrigiorgos GM
Clin Chem; 2018 Dec; 64(12):1762-1771. PubMed ID: 30274976
[TBL] [Abstract][Full Text] [Related]
4. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
[TBL] [Abstract][Full Text] [Related]
5. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA.
Chen L; Ma R; Luo C; Xie Q; Ning X; Sun K; Meng F; Zhou M; Sun J
Transl Res; 2023 Dec; 262():12-24. PubMed ID: 37499745
[TBL] [Abstract][Full Text] [Related]
7. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
9. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
10. Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier.
Yu D; Liu Z; Su C; Han Y; Duan X; Zhang R; Liu X; Yang Y; Xu S
Thorac Cancer; 2020 Jan; 11(1):95-102. PubMed ID: 31694073
[TBL] [Abstract][Full Text] [Related]
11. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
[TBL] [Abstract][Full Text] [Related]
12. A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
Bortul M; Giudici F; Tierno D; Generali D; Scomersi S; Grassi G; Bottin C; Cappelletti MR; Zanconati F; Scaggiante B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239866
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations.
Boons G; Vandamme T; Peeters M; Beyens M; Driessen A; Janssens K; Zwaenepoel K; Roeyen G; Van Camp G; Op de Beeck K
Front Oncol; 2018; 8():467. PubMed ID: 30443491
[No Abstract] [Full Text] [Related]
14. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract][Full Text] [Related]
15. KITLG Copy Number Germline Variations in Schnauzer Breeds and Their Relevance in Digital Squamous Cell Carcinoma in Black Giant Schnauzers.
Aupperle-Lellbach H; Heidrich D; Kehl A; Conrad D; Brockmann M; Törner K; Beitzinger C; Müller T
Vet Sci; 2023 Feb; 10(2):. PubMed ID: 36851451
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.
Youssef SS; El-Araby RE; Abbas EAE; Hassany M; Elbaz T
Expert Rev Mol Diagn; 2023 Mar; 23(3):267-278. PubMed ID: 36803362
[TBL] [Abstract][Full Text] [Related]
17. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Du M; Thompson J; Fisher H; Zhang P; Huang CC; Wang L
Lung Cancer; 2018 Jun; 120():113-121. PubMed ID: 29748005
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
Yang X; Zhang K; Zhang C; Peng R; Sun C
BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
[TBL] [Abstract][Full Text] [Related]
19. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of copy number alterations by liquid biopsy for neuroblastoma.
Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Ishiwata K; Yamada Y; Yoshida M; Yoshida K; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Takasugi N; Takita J; Miyazaki O; Kiyokawa N; Yoneda A; Kanamori Y; Hishiki T; Matsumoto K; Hata K; Yoshioka T; Kato M
Genes Chromosomes Cancer; 2022 Nov; 61(11):662-669. PubMed ID: 35655408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]